ARCHIVES

Also FDA clarifies data requirements for phase I IND applications.

This article is from The Cancer Letter archive.

Vol. 31 No. 17 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Louisville Cancer Center Developed With No Federal, State Money Or Fund Raising Costs

May 30, 1980

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

May 25, 2012

ASCO Members Pick Schilsky as President-Elect; Five Elected to Society’s Board of Directors.

February 16, 2007

Univ. Of Pennsylvania Ordered to Review all NIH Research

October 11, 1985

Clinical Trials Approved By NCI

September 26, 2003

Women Surgeons: We Need Answers On Tamoxifin Now

May 13, 1994